However, such differences appear to lessen after menopause, with postmenopausal women showing the least metabolic benefit, likely due to hormonal and BC changes [139, 140]
As highlighted by specialists in the area, incorporating this medication into a tailored health management plan, supported by continuous guidance, can empower women to regain their well-being during these critical life phases
With the implicit validity of these data given the expected weight regain seen after therapy cessation, there is some credence to the idea that this is a genuine reflection of nondurability of weight loss with GLP-1 receptor agonist therapy
This approach requires highly precise measurement, which is challenging with compounded vials
Please be sure to adjust based on your personal needs, preferences, allergies, etc
The way that you look does not define your worth, doesn't define your lovableness